Literature DB >> 9175519

Mitochondrial cardiomyopathy: molecular and biochemical analysis.

J Marin-Garcia1, M J Goldenthal.   

Abstract

Abnormalities in cardiac mitochondrial respiratory enzymes and mitochondrial DNA have been found in an increasing number of pediatric cases of both dilated and hypertrophic cardiomyopathy, giving rise to the entity known as mitochondrial cardiomyopathy. Histochemical, biochemical, and molecular findings are described in this review of mitochondrial cardiomyopathy, which should provide assistance in its diagnostic identification.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9175519     DOI: 10.1007/s002469900169

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  10 in total

1.  Mitochondrial myopathy presenting as ataxia with dilated cardiomyopathy.

Authors:  S Gulati; A Das Gupta; M Kabra; R Juneja; M C Sharma; V Kalra
Journal:  Indian J Pediatr       Date:  2001-04       Impact factor: 1.967

Review 2.  The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications.

Authors:  Iain P Hargreaves; Andrew J Duncan; Simon J R Heales; John M Land
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  RXRalpha overexpression in cardiomyocytes causes dilated cardiomyopathy but fails to rescue myocardial hypoplasia in RXRalpha-null fetuses.

Authors:  V Subbarayan; M Mark; N Messadeq; P Rustin; P Chambon; P Kastner
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

4.  Biochemical and molecular basis for mitochondrial cardiomyopathy in neonates and children.

Authors:  J Marin-Garcia; R Ananthakrishnan; M J Goldenthal; M E Pierpont
Journal:  J Inherit Metab Dis       Date:  2000-09       Impact factor: 4.982

5.  Dramatic improvement in mitochondrial cardiomyopathy following treatment with idebenone.

Authors:  T Lerman-Sagie; P Rustin; D Lev; M Yanoov; E Leshinsky-Silver; A Sagie; T Ben-Gal; A Munnich
Journal:  J Inherit Metab Dis       Date:  2001-02       Impact factor: 4.982

Review 6.  Role of copper in mitochondrial biogenesis via interaction with ATP synthase and cytochrome c oxidase.

Authors:  Denis M Medeiros; Dianne Jennings
Journal:  J Bioenerg Biomembr       Date:  2002-10       Impact factor: 2.945

7.  Clinical presentations of mitochondrial cardiomyopathies.

Authors:  D Lev; A Nissenkorn; E Leshinsky-Silver; M Sadeh; A Zeharia; B-Z Garty; L Blieden; V Barash; T Lerman-Sagie
Journal:  Pediatr Cardiol       Date:  2004-06-08       Impact factor: 1.655

Review 8.  Diagnosis and treatment of mitochondrial myopathies.

Authors:  Gerald Pfeffer; Patrick F Chinnery
Journal:  Ann Med       Date:  2011-08-25       Impact factor: 4.709

9.  Cardiomyocyte specific deletion of Crif1 causes mitochondrial cardiomyopathy in mice.

Authors:  Juhee Shin; Seok Hong Lee; Min-Chul Kwon; Dong Kwon Yang; Ha-Rim Seo; Jaetaek Kim; Yoon-Young Kim; Sun-Kyoung Im; Evan Dale Abel; Kyong-Tai Kim; Woo Jin Park; Young-Yun Kong
Journal:  PLoS One       Date:  2013-01-04       Impact factor: 3.240

10.  MT-CYB mutations in hypertrophic cardiomyopathy.

Authors:  Christian M Hagen; Frederik H Aidt; Ole Havndrup; Paula L Hedley; Cathrine Jespersgaard; Morten Jensen; Jørgen K Kanters; Johanna C Moolman-Smook; Daniel V Møller; Henning Bundgaard; Michael Christiansen
Journal:  Mol Genet Genomic Med       Date:  2013-04-12       Impact factor: 2.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.